S
Sygnature Discovery
An independent provider of integrated drug discovery resource and expertise
At a glance
- Founded
- 2004
- Headquarters
- Nottingham, United Kingdom
- Sector
- Biotech & Life Sciences
- Power Law
- Thoroughbred$100M+ revenue
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later1 investor entered at this stage
- PPPhoenix Equity Partners
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Patents
6 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Investments and acquisitions
Disclosed deals where Sygnature Discovery was the backer or acquirer, 2017–2023. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
5 deals across Sygnature Discovery's capital deployment.
Where the deals concentrate by sector, stage, and decade.
Sygnature Discovery's portfolio, mapped.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Sygnature Discovery on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Sygnature Discovery on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.